Sandra L. Hatten

Filings by Sandra L. Hatten span 2 companies, the busiest being Avadel Pharmaceuticals PLC and Mallinckrodt plc. Between 1 March 2014 and 12 December 2019, the trades on record add up to 27 filings.

Both buying and selling appear: 5 purchases worth €76k, against 5 sales worth €282k. Taken together, the sales exceed the purchases by €206k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 14 share grants and 2 option exercises. In 2019 alone, the filings show no purchases and 1 sale.

Half of the purchases are above €16k and half below. On 5 out of 5 purchases, another insider of the same company was buying within the same 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.

Most recently, on 16 December 2019, the filings show an open-market sale worth €20k in Avadel Pharmaceuticals PLC. The clock since the last published purchase (15 September 2017) now reads 3,342 days. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.